MedPath

Comparison of the Effect of Remifentanil and Nitroglycerin on Intraoperative Blood Pressure and Complications During and After Rhinoplasty

Phase 2
Conditions
Rhinoplasty.
General- and plastic-surgery devices associated with adverse incidents
Registration Number
IRCT20210508051228N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

1-Age between 18 and 45 years 2- Classification of the American Anesthesia Association in Physical Classes 1 and 2 3- Satisfaction of the company in the project 4-No history of bleeding disorders in the patient 5-No history of hypertension in the patient 6-Do not take drugs that alter coagulation profiles such as aspirin 7-Platelet counts and normal coagulation tests

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before, during and after rhinoplasty. Method of measurement: The vital signs monitoring device of Mizan Teb Company.
Secondary Outcome Measures
NameTimeMethod
The surgeon's satisfaction with the surgical site. Timepoint: Before, during and after rhinoplasty. Method of measurement: Vital Signs Monitoring Company of Mizan Teb Company.
© Copyright 2025. All Rights Reserved by MedPath